Other Species / Isoforms
  VIPAS39 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K5
___MNRTKGDEEEyW
0 1
VIPAS39 (human) ___MNRTkGDEEEyW K5-ub
VIPAS39 iso2 (human) ___MNRTKGDEEEYW K5
VIPAS39 (mouse) ___MNRTKGDEEEyW K5
VIPAS39 (rat) ___MNRTKGDEEEYW K5
Y11-p
TKGDEEEyWNSSKFK
1 319
VIPAS39 (human) TkGDEEEyWNSskFk Y11-p
VIPAS39 iso2 (human) TKGDEEEYWNSSKFK Y11
VIPAS39 (mouse) TKGDEEEyWNSSKFK Y11-p
VIPAS39 (rat) TKGDEEEYWNSSKFK Y11
S15
EEEyWNSSKFKAFtF
0 2
VIPAS39 (human) EEEyWNSskFkAFtF S15-p
VIPAS39 iso2 (human) EEEYWNSSKFKAFTF S15
VIPAS39 (mouse) EEEyWNSSKFKAFtF S15
VIPAS39 (rat) EEEYWNSSKFKAFTF S15
K16
EEyWNSSKFKAFtFD
0 1
VIPAS39 (human) EEyWNSskFkAFtFD K16-ub
VIPAS39 iso2 (human) EEYWNSSKFKAFTFD K16
VIPAS39 (mouse) EEyWNSSKFKAFtFD K16
VIPAS39 (rat) EEYWNSSKFKAFTFD K16
K18
yWNSSKFKAFtFDDE
0 1
VIPAS39 (human) yWNSskFkAFtFDDE K18-ub
VIPAS39 iso2 (human) YWNSSKFKAFTFDDE K18
VIPAS39 (mouse) yWNSSKFKAFtFDDE K18
VIPAS39 (rat) YWNSSKFKAFTFDDE K18
T21-p
SSKFKAFtFDDEDDE
0 16
VIPAS39 (human) SskFkAFtFDDEDDE T21-p
VIPAS39 iso2 (human) SSKFKAFTFDDEDDE T21
VIPAS39 (mouse) SSKFKAFtFDDEDDE T21-p
VIPAS39 (rat) SSKFKAFTFDDEDDE T21
S30
DDEDDELSQLKESKR
0 1
VIPAS39 (human) DDEDDELsQLkESKR S30-p
VIPAS39 iso2 (human) DDEDDELSQLKESKR S30
VIPAS39 (mouse) DDEDDELSQLKESKR S30
VIPAS39 (rat) DDEDDELSQLKESKR S30
K33
DDELSQLKESKRAVN
0 1
VIPAS39 (human) DDELsQLkESKRAVN K33-ub
VIPAS39 iso2 (human) DDELSQLKESKRAVN K33
VIPAS39 (mouse) DDELSQLKESKRAVN K33
VIPAS39 (rat) DDELSQLKESKRAVN K33
T74-p
ISWSIKEtAGssGST
0 2
VIPAS39 (human) ISWSIRETAGNSGST T74
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) ISWSIKEtAGssGST T74-p
VIPAS39 (rat) ISWSIKETAGSSGST T74
S77-p
SIKEtAGssGSTPEG
0 2
VIPAS39 (human) SIRETAGNSGSTHEG N77
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) SIKEtAGssGSTPEG S77-p
VIPAS39 (rat) SIKETAGSSGSTSEG S77
S78-p
IKEtAGssGSTPEGR
0 2
VIPAS39 (human) IRETAGNSGSTHEGR S78
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) IKEtAGssGSTPEGR S78-p
VIPAS39 (rat) IKETAGSSGSTSEGR S78
G90
EGREQLKGRNSFYTQ
0 5
VIPAS39 (human) EGREQLKsRNsFssy S90-p
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) EGREQLKGRNSFYTQ G90
VIPAS39 (rat) EGREQMKGRNSFyTQ G90
S93
EQLKGRNSFYTQLPK
0 60
VIPAS39 (human) EQLKsRNsFssyAQL S93-p
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) EQLKGRNSFYTQLPK S93
VIPAS39 (rat) EQMKGRNSFyTQLPK S93
-
gap
0 2
VIPAS39 (human) LKsRNsFssyAQLPK S95-p
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) gap -
VIPAS39 (rat) gap -
-
gap
0 7
VIPAS39 (human) KsRNsFssyAQLPKP S96-p
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) gap -
VIPAS39 (rat) gap -
Y95
LKGRNSFYTQLPKPP
0 15
VIPAS39 (human) sRNsFssyAQLPKPt Y97-p
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) LKGRNSFYTQLPKPP Y95
VIPAS39 (rat) MKGRNSFyTQLPKPP Y95-p
P102
YTQLPKPPstYsLSS
0 3
VIPAS39 (human) yAQLPKPtstysLSS T104-p
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) YTQLPKPPstYsLSS P102
VIPAS39 (rat) yTQLPKPPSTYSLSS P102
S103-p
TQLPKPPstYsLSSF
Upstream
0 35
Treatment
  • insulin
  • ischemia
  • MK-2206
VIPAS39 (human) AQLPKPtstysLSSF S105-p
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) TQLPKPPstYsLSSF S103-p
VIPAS39 (rat) TQLPKPPSTYSLSSF S103
T104-p
QLPKPPstYsLSSFF
0 4
VIPAS39 (human) QLPKPtstysLSSFF T106-p
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) QLPKPPstYsLSSFF T104-p
VIPAS39 (rat) QLPKPPSTYSLSSFF T104
Y105
LPKPPstYsLSSFFR
0 2
VIPAS39 (human) LPKPtstysLSSFFr Y107-p
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) LPKPPstYsLSSFFR Y105
VIPAS39 (rat) LPKPPSTYSLSSFFR Y105
S106-p
PKPPstYsLSSFFRG
Upstream
0 2
Treatment
  • insulin
  • MK-2206
VIPAS39 (human) PKPtstysLSSFFrG S108-p
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) PKPPstYsLSSFFRG S106-p
VIPAS39 (rat) PKPPSTYSLSSFFRG S106
R112
YsLSSFFRGRTRPGs
0 9
VIPAS39 (human) ysLSSFFrGRtrPGs R114-m1
VIPAS39 iso2 (human) gap -
VIPAS39 (mouse) YsLSSFFRGRTRPGs R112
VIPAS39 (rat) YSLSSFFRGRTRPGs R112
T115
SSFFRGRTRPGsFQs
0 3
VIPAS39 (human) SSFFrGRtrPGsFQs T117-p
VIPAS39 iso2 (human) GEPVGSRTRPGSFQS T68
VIPAS39 (mouse) SSFFRGRTRPGsFQs T115
VIPAS39 (rat) SSFFRGRTRPGsFQs T115
R116
SFFRGRTRPGsFQsL
0 1
VIPAS39 (human) SFFrGRtrPGsFQsL R118-m1
VIPAS39 iso2 (human) EPVGSRTRPGSFQSL R69
VIPAS39 (mouse) SFFRGRTRPGsFQsL R116
VIPAS39 (rat) SFFRGRTRPGsFQsL R116
S119-p
RGRTRPGsFQsLsDA
Upstream
0 262
Treatment
  • insulin
  • LPA
  • LPS
  • LY294002
  • MK-2206
  • PDGF
VIPAS39 (human) rGRtrPGsFQsLsDA S121-p
VIPAS39 iso2 (human) GSRTRPGSFQSLSDA S72
VIPAS39 (mouse) RGRTRPGsFQsLsDA S119-p
VIPAS39 (rat) RGRTRPGsFQsLSDA S119-p
S122-p
TRPGsFQsLsDALsD
Upstream
0 67
Treatment
  • LPA
VIPAS39 (human) trPGsFQsLsDALsD S124-p
VIPAS39 iso2 (human) TRPGSFQSLSDALSD S75
VIPAS39 (mouse) TRPGsFQsLsDALsD S122-p
VIPAS39 (rat) TRPGsFQsLSDALSD S122-p
S124-p
PGsFQsLsDALsDtP
0 9
VIPAS39 (human) PGsFQsLsDALsDtP S126-p
VIPAS39 iso2 (human) PGSFQSLSDALSDTP S77
VIPAS39 (mouse) PGsFQsLsDALsDtP S124-p
VIPAS39 (rat) PGsFQsLSDALSDTP S124
S128-p
QsLsDALsDtPAKSY
0 4
VIPAS39 (human) QsLsDALsDtPAKsY S130-p
VIPAS39 iso2 (human) QSLSDALSDTPAKSY S81
VIPAS39 (mouse) QsLsDALsDtPAKSY S128-p
VIPAS39 (rat) QsLSDALSDTPAKTY S128
T130-p
LsDALsDtPAKSYAP
0 25
VIPAS39 (human) LsDALsDtPAKsYAP T132-p
VIPAS39 iso2 (human) LSDALSDTPAKSYAP T83
VIPAS39 (mouse) LsDALsDtPAKSYAP T130-p
VIPAS39 (rat) LSDALSDTPAKTYSP T130
S134
LsDtPAKSYAPELGR
0 1
VIPAS39 (human) LsDtPAKsYAPELGR S136-p
VIPAS39 iso2 (human) LSDTPAKSYAPELGR S87
VIPAS39 (mouse) LsDtPAKSYAPELGR S134
VIPAS39 (rat) LSDTPAKTYSPELGR T134
K143
APELGRPKGEYRDYS
0 2
VIPAS39 (human) APELGRPkGEYRDyS K145-ub
VIPAS39 iso2 (human) APELGRPKGEYRDYS K96
VIPAS39 (mouse) APELGRPKGEYRDYS K143
VIPAS39 (rat) SPELGRPKGEYRDYS K143
Y149
PKGEYRDYSNDWSLS
0 2
VIPAS39 (human) PkGEYRDySNDWsPS Y151-p
VIPAS39 iso2 (human) PKGEYRDYSNDWSPS Y102
VIPAS39 (mouse) PKGEYRDYSNDWSLS Y149
VIPAS39 (rat) PKGEYRDYSNDWSLS Y149
S154
RDYSNDWSLSDTVQR
0 1
VIPAS39 (human) RDySNDWsPSDTVRR S156-p
VIPAS39 iso2 (human) RDYSNDWSPSDTVRR S107
VIPAS39 (mouse) RDYSNDWSLSDTVQR S154
VIPAS39 (rat) RDYSNDWSLSDTVRR S154
K166
VQRLRRGKVCSLERF
0 2
VIPAS39 (human) VRRLRKGkVCSLERF K168-ub
VIPAS39 iso2 (human) VRRLRKGKVCSLERF K119
VIPAS39 (mouse) VQRLRRGKVCSLERF K166
VIPAS39 (rat) VRRLRQGKVLIFLKR K166
K273
EKRKEFLKTCIGLPF
0 1
VIPAS39 (human) DKRKEFLkTCVGLPF K275-ub
VIPAS39 iso2 (human) DKRKEFLKTCVGLPF K226
VIPAS39 (mouse) EKRKEFLKTCIGLPF K273
VIPAS39 (rat) EKRKEFLKTCIGLPF K242
Y341
TLFYACFYHYTESEG
0 1
VIPAS39 (human) TLFYSCFyHYTEAEG Y343-p
VIPAS39 iso2 (human) TLFYSCFYHYTEAEG Y294
VIPAS39 (mouse) TLFYACFYHYTESEG Y341
VIPAS39 (rat) TLFYACFYHYTESEG Y310
K361
INLKKTFKIPDKQYV
0 2
VIPAS39 (human) VNLKKTFkIPDKQYV K363-ub
VIPAS39 iso2 (human) VNLKKTFKIPDKQYV K314
VIPAS39 (mouse) INLKKTFKIPDKQYV K361
VIPAS39 (rat) VNLKKTFKIPDRQYV K330
K391
VDALFTTKNWLGYTK
0 1
VIPAS39 (human) VDALFTTkNWLGYTK K393-ub
VIPAS39 iso2 (human) VDALFTTKNWLGYTK K344
VIPAS39 (mouse) VDALFTTKNWLGYTK K391
VIPAS39 (rat) VDALFTTKNWLGYTK K360
S466
QQLLAYRSKVDKGSA
0 1
VIPAS39 (human) QQLLAYRSKVDKGSA S468
VIPAS39 iso2 (human) QQLLAYRSKVDKGSA S419
VIPAS39 (mouse) QQLLAYRSKVDKGSA S466
VIPAS39 (rat) QQLLAYRsKVDKGSA S435-p
K477
KGSAEEEKIDAILSS
0 1
VIPAS39 (human) KGSAEEEkIDALLSS K479-ub
VIPAS39 iso2 (human) KGSAEEEKIDALLSS K430
VIPAS39 (mouse) KGSAEEEKIDAILSS K477
VIPAS39 (rat) KGSAEEEKIDVILSS K446
S485
IDAILSSSQIRWKN_
0 1
VIPAS39 (human) IDALLSSsQIRWKN_ S487-p
VIPAS39 iso2 (human) IDALLSSSQIRWKN_ S438
VIPAS39 (mouse) IDAILSSSQIRWKN_ S485
VIPAS39 (rat) IDVILSSSQIRWKN_ S454